277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc..
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 277
Januvia
- Generic Name:
- sitagliptin
- Imprint:
- 277
- Strength:
- 100 mg
- Color:
- Brown
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Merck & Company Inc.
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 54569-5925 | A-S Medication Solutions, LLC (repackager) |
| 54868-5840 | Physicians Total Care Inc. (repackager) |
| 35356-0103 | Lake Erie Medical and Surgical Supply (repackager) |
More about Januvia (sitagliptin)
- Januvia Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 70 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
